Rank | Gene Set | Z-score |
---|---|---|
1 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.96109292 |
2 | cell communication involved in cardiac conduction (GO:0086065) | 3.66892896 |
3 | cell migration in hindbrain (GO:0021535) | 3.63129006 |
4 | cell communication by electrical coupling (GO:0010644) | 3.56529675 |
5 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.53675781 |
6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.46422931 |
7 | neuronal ion channel clustering (GO:0045161) | 3.32278828 |
8 | synaptic vesicle maturation (GO:0016188) | 3.24128436 |
9 | positive regulation of synapse maturation (GO:0090129) | 3.20866534 |
10 | sodium ion export (GO:0071436) | 3.17869327 |
11 | auditory behavior (GO:0031223) | 3.15989980 |
12 | neuron cell-cell adhesion (GO:0007158) | 3.15766005 |
13 | cerebellar granule cell differentiation (GO:0021707) | 3.15297024 |
14 | lysine metabolic process (GO:0006553) | 3.15105153 |
15 | lysine catabolic process (GO:0006554) | 3.15105153 |
16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.06873092 |
17 | L-phenylalanine catabolic process (GO:0006559) | 3.06873092 |
18 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.06602428 |
19 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.06518930 |
20 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.01621226 |
21 | innervation (GO:0060384) | 2.99177710 |
22 | axonal fasciculation (GO:0007413) | 2.99040183 |
23 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.95926951 |
24 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.94235789 |
25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.93188478 |
26 | L-phenylalanine metabolic process (GO:0006558) | 2.93188478 |
27 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.91785385 |
28 | dendritic spine organization (GO:0097061) | 2.89194157 |
29 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.88321653 |
30 | vocalization behavior (GO:0071625) | 2.86559516 |
31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.85261871 |
32 | glutamate secretion (GO:0014047) | 2.83660010 |
33 | locomotory exploration behavior (GO:0035641) | 2.83613577 |
34 | cellular potassium ion homeostasis (GO:0030007) | 2.81589064 |
35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.81021094 |
36 | neuron recognition (GO:0008038) | 2.79881823 |
37 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.79358806 |
38 | activation of protein kinase A activity (GO:0034199) | 2.78854651 |
39 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.77147399 |
40 | postsynaptic membrane organization (GO:0001941) | 2.76809104 |
41 | desmosome organization (GO:0002934) | 2.76639241 |
42 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.75815072 |
43 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.75501565 |
44 | neurotransmitter secretion (GO:0007269) | 2.74291768 |
45 | membrane repolarization during action potential (GO:0086011) | 2.72950361 |
46 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.70626347 |
47 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.67531026 |
48 | cardiac conduction (GO:0061337) | 2.66821889 |
49 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.66132090 |
50 | synaptic vesicle endocytosis (GO:0048488) | 2.65826993 |
51 | aspartate family amino acid catabolic process (GO:0009068) | 2.65133838 |
52 | membrane repolarization (GO:0086009) | 2.64922131 |
53 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.64791113 |
54 | drug catabolic process (GO:0042737) | 2.64430598 |
55 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.63430246 |
56 | chemosensory behavior (GO:0007635) | 2.63189738 |
57 | 2-oxoglutarate metabolic process (GO:0006103) | 2.62945271 |
58 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.62495680 |
59 | regulation of cholesterol homeostasis (GO:2000188) | 2.62365197 |
60 | cell-cell junction maintenance (GO:0045217) | 2.60965767 |
61 | regulation of membrane repolarization (GO:0060306) | 2.60771123 |
62 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.59311990 |
63 | synaptic vesicle exocytosis (GO:0016079) | 2.59063681 |
64 | protein localization to synapse (GO:0035418) | 2.58828994 |
65 | apical protein localization (GO:0045176) | 2.58584299 |
66 | membrane depolarization during action potential (GO:0086010) | 2.58225660 |
67 | cellular ketone body metabolic process (GO:0046950) | 2.58179377 |
68 | macroautophagy (GO:0016236) | 2.57321146 |
69 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.56823585 |
70 | exploration behavior (GO:0035640) | 2.55609310 |
71 | response to auditory stimulus (GO:0010996) | 2.55032987 |
72 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.54208243 |
73 | kynurenine metabolic process (GO:0070189) | 2.54057017 |
74 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.53294003 |
75 | alpha-linolenic acid metabolic process (GO:0036109) | 2.53164802 |
76 | potassium ion homeostasis (GO:0055075) | 2.52915014 |
77 | glutamate metabolic process (GO:0006536) | 2.52756597 |
78 | potassium ion import (GO:0010107) | 2.51860103 |
79 | aromatic amino acid family catabolic process (GO:0009074) | 2.51756002 |
80 | neuromuscular synaptic transmission (GO:0007274) | 2.51518035 |
81 | carnitine shuttle (GO:0006853) | 2.51151819 |
82 | detection of calcium ion (GO:0005513) | 2.50278862 |
83 | synaptic transmission, glutamatergic (GO:0035249) | 2.49904195 |
84 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.49315970 |
85 | axon ensheathment in central nervous system (GO:0032291) | 2.49214099 |
86 | central nervous system myelination (GO:0022010) | 2.49214099 |
87 | relaxation of cardiac muscle (GO:0055119) | 2.49072107 |
88 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.49042485 |
89 | cell junction maintenance (GO:0034331) | 2.48475613 |
90 | regulation of synapse maturation (GO:0090128) | 2.48363161 |
91 | plasma membrane repair (GO:0001778) | 2.47547726 |
92 | enteric nervous system development (GO:0048484) | 2.47499214 |
93 | mating behavior (GO:0007617) | 2.47140724 |
94 | regulation of synapse structural plasticity (GO:0051823) | 2.46143601 |
95 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.45348172 |
96 | cochlea development (GO:0090102) | 2.45006614 |
97 | suckling behavior (GO:0001967) | 2.44593594 |
98 | regulation of neurotransmitter levels (GO:0001505) | 2.44165539 |
99 | nucleobase catabolic process (GO:0046113) | 2.42492052 |
100 | dopamine receptor signaling pathway (GO:0007212) | 2.42339162 |
101 | regulation of synaptic vesicle transport (GO:1902803) | 2.41994874 |
102 | gamma-aminobutyric acid transport (GO:0015812) | 2.41884491 |
103 | layer formation in cerebral cortex (GO:0021819) | 2.41269095 |
104 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.41156814 |
105 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.40177206 |
106 | drug transmembrane transport (GO:0006855) | 2.39996749 |
107 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.39614721 |
108 | glutamate receptor signaling pathway (GO:0007215) | 2.39579548 |
109 | cellular sodium ion homeostasis (GO:0006883) | 2.38146154 |
110 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.37487314 |
111 | exogenous drug catabolic process (GO:0042738) | 2.36855356 |
112 | dendrite morphogenesis (GO:0048813) | 2.36761666 |
113 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.36702789 |
114 | cardiac muscle contraction (GO:0060048) | 2.36623741 |
115 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.35649964 |
116 | cell differentiation in hindbrain (GO:0021533) | 2.35518826 |
117 | glyoxylate metabolic process (GO:0046487) | 2.34814435 |
118 | positive regulation of membrane potential (GO:0045838) | 2.33663989 |
119 | short-chain fatty acid metabolic process (GO:0046459) | 2.33648955 |
120 | fatty acid transmembrane transport (GO:1902001) | 2.32790639 |
121 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.32346034 |
122 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.32288013 |
123 | neuromuscular process controlling posture (GO:0050884) | 2.32081852 |
124 | proline transport (GO:0015824) | 2.31777088 |
125 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.30648959 |
126 | positive regulation of dendritic spine development (GO:0060999) | 2.30344505 |
127 | regulation of bile acid biosynthetic process (GO:0070857) | 2.30245968 |
128 | neuromuscular process controlling balance (GO:0050885) | 2.29653223 |
129 | sulfur amino acid catabolic process (GO:0000098) | 2.29418787 |
130 | sarcomere organization (GO:0045214) | 2.29337813 |
131 | regulation of neurotransmitter secretion (GO:0046928) | 2.29039508 |
132 | synapse assembly (GO:0007416) | 2.28499050 |
133 | positive regulation of potassium ion transport (GO:0043268) | 2.27233863 |
134 | transmission of nerve impulse (GO:0019226) | 2.26913307 |
135 | neuron-neuron synaptic transmission (GO:0007270) | 2.26664711 |
136 | lung epithelium development (GO:0060428) | 2.26454032 |
137 | glycine transport (GO:0015816) | 2.26166509 |
138 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.25715322 |
139 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.25676186 |
140 | multicellular organismal signaling (GO:0035637) | 2.25567916 |
141 | sympathetic nervous system development (GO:0048485) | 2.25538903 |
142 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.25494345 |
143 | dicarboxylic acid catabolic process (GO:0043649) | 2.25461724 |
144 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.24565556 |
145 | protein targeting to Golgi (GO:0000042) | 2.24262379 |
146 | neurotransmitter transport (GO:0006836) | 2.24182500 |
147 | positive regulation of neurotransmitter transport (GO:0051590) | 2.24115591 |
148 | neuron maturation (GO:0042551) | 2.24027263 |
149 | presynaptic membrane organization (GO:0097090) | 2.23607538 |
150 | positive regulation of sodium ion transport (GO:0010765) | 2.23599957 |
151 | regulation of postsynaptic membrane potential (GO:0060078) | 2.23469574 |
152 | cardiac muscle cell action potential (GO:0086001) | 2.23423652 |
153 | regulation of ARF protein signal transduction (GO:0032012) | 2.23132980 |
154 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.22260531 |
155 | growth hormone secretion (GO:0030252) | 2.21609095 |
156 | cellular modified amino acid catabolic process (GO:0042219) | 2.21066844 |
157 | regulation of synaptic plasticity (GO:0048167) | 2.20862553 |
158 | behavioral response to nicotine (GO:0035095) | 2.20828655 |
159 | tricarboxylic acid cycle (GO:0006099) | 2.20403618 |
160 | sodium ion homeostasis (GO:0055078) | 2.20344596 |
161 | negative regulation of catenin import into nucleus (GO:0035414) | 2.19323052 |
162 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.19178972 |
163 | dendritic spine morphogenesis (GO:0060997) | 2.19126337 |
164 | synapse organization (GO:0050808) | 2.19082811 |
165 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.18365682 |
166 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.18095143 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.80919283 |
2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.10698558 |
3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.36641492 |
4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.27786606 |
5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.16836634 |
6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.08084868 |
7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.02048616 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.97339435 |
9 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.95280526 |
10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.95268565 |
11 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.90951374 |
12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.87173204 |
13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.87173204 |
14 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.85052219 |
15 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.83183572 |
16 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.82834791 |
17 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.80979769 |
18 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.80809979 |
19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76580773 |
20 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.75893870 |
21 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.73732879 |
22 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.70720825 |
23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.69984049 |
24 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.68174613 |
25 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.64070009 |
26 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.58207816 |
27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58034155 |
28 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.57112301 |
29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.54092159 |
30 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.52734210 |
31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.52455621 |
32 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52356638 |
33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.44372760 |
34 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.44054217 |
35 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.42776386 |
36 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.41969267 |
37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.41632722 |
38 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40815086 |
39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39615985 |
40 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.38357255 |
41 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37260012 |
42 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.36900746 |
43 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36889481 |
44 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31684443 |
45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.30646843 |
46 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28225553 |
47 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.26106890 |
48 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25703748 |
49 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.24869395 |
50 | KDM2B_26808549_Chip-Seq_K562_Human | 1.23535614 |
51 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23397091 |
52 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.22165098 |
53 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.19864504 |
54 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.17394483 |
55 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.17162999 |
56 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.16313059 |
57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16125443 |
58 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15828366 |
59 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14561232 |
60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.14379347 |
61 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.14043556 |
62 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.11992193 |
63 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.11616653 |
64 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10669999 |
65 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.09842852 |
66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.09168085 |
67 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08657611 |
68 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.07012266 |
69 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.06998407 |
70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.06657838 |
71 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.04902894 |
72 | AR_19668381_ChIP-Seq_PC3_Human | 1.04397534 |
73 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.04086155 |
74 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03534066 |
75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02649068 |
76 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.02474812 |
77 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.01874700 |
78 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.00723760 |
79 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.00464908 |
80 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00257365 |
81 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.99278279 |
82 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97681680 |
83 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.97029863 |
84 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95000814 |
85 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.94332051 |
86 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.93879678 |
87 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.92697736 |
88 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92154275 |
89 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.91881317 |
90 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.91881317 |
91 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91784156 |
92 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91419236 |
93 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.91095310 |
94 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.90306362 |
95 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.89755805 |
96 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89459927 |
97 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88924324 |
98 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87361165 |
99 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.87263597 |
100 | STAT3_23295773_ChIP-Seq_U87_Human | 0.85474503 |
101 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.85279790 |
102 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84466315 |
103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.84339918 |
104 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.84051044 |
105 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83333808 |
106 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.83181027 |
107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.82133364 |
108 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.82021802 |
109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.81639292 |
110 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.81552603 |
111 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.81322152 |
112 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.80905582 |
113 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.80796617 |
114 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.80077983 |
115 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.79344238 |
116 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79319233 |
117 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.79251549 |
118 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79045999 |
119 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79028523 |
120 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.78998399 |
121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.78109662 |
122 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.77893719 |
123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77875705 |
124 | AR_25329375_ChIP-Seq_VCAP_Human | 0.76951398 |
125 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.76303634 |
126 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.76288934 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002837_dystrophic_cardiac_calcinosis | 3.60891047 |
2 | MP0002139_abnormal_hepatobiliary_system | 3.40247181 |
3 | MP0005360_urolithiasis | 3.25951833 |
4 | MP0004859_abnormal_synaptic_plasticity | 3.11155987 |
5 | MP0005085_abnormal_gallbladder_physiolo | 2.89950725 |
6 | MP0005365_abnormal_bile_salt | 2.74828421 |
7 | MP0004270_analgesia | 2.59243394 |
8 | MP0002909_abnormal_adrenal_gland | 2.51079683 |
9 | MP0009780_abnormal_chondrocyte_physiolo | 2.38068380 |
10 | MP0002822_catalepsy | 2.31017821 |
11 | MP0004043_abnormal_pH_regulation | 2.25895261 |
12 | MP0000751_myopathy | 2.15638776 |
13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.13429498 |
14 | MP0003635_abnormal_synaptic_transmissio | 2.10609264 |
15 | MP0003252_abnormal_bile_duct | 2.04265532 |
16 | MP0000566_synostosis | 1.98594333 |
17 | MP0003880_abnormal_central_pattern | 1.98512277 |
18 | MP0004215_abnormal_myocardial_fiber | 1.90611784 |
19 | MP0003195_calcinosis | 1.87040947 |
20 | MP0003787_abnormal_imprinting | 1.85575706 |
21 | MP0003123_paternal_imprinting | 1.79656245 |
22 | MP0004084_abnormal_cardiac_muscle | 1.74028300 |
23 | MP0003283_abnormal_digestive_organ | 1.73167637 |
24 | MP0004858_abnormal_nervous_system | 1.73126362 |
25 | MP0001968_abnormal_touch/_nociception | 1.69279846 |
26 | MP0002734_abnormal_mechanical_nocicepti | 1.68951419 |
27 | MP0003646_muscle_fatigue | 1.68591704 |
28 | MP0008961_abnormal_basal_metabolism | 1.68450168 |
29 | MP0000778_abnormal_nervous_system | 1.66326781 |
30 | MP0004036_abnormal_muscle_relaxation | 1.62218027 |
31 | MP0005409_darkened_coat_color | 1.60732716 |
32 | MP0009745_abnormal_behavioral_response | 1.59921453 |
33 | MP0010329_abnormal_lipoprotein_level | 1.58924276 |
34 | MP0002063_abnormal_learning/memory/cond | 1.58660632 |
35 | MP0005083_abnormal_biliary_tract | 1.57488447 |
36 | MP0005423_abnormal_somatic_nervous | 1.54222594 |
37 | MP0002638_abnormal_pupillary_reflex | 1.53490068 |
38 | MP0002064_seizures | 1.51682817 |
39 | MP0003329_amyloid_beta_deposits | 1.50284681 |
40 | MP0009046_muscle_twitch | 1.49320672 |
41 | MP0002735_abnormal_chemical_nociception | 1.48901509 |
42 | MP0006276_abnormal_autonomic_nervous | 1.46843719 |
43 | MP0001666_abnormal_nutrient_absorption | 1.43687286 |
44 | MP0002272_abnormal_nervous_system | 1.38435406 |
45 | MP0000534_abnormal_ureter_morphology | 1.36688646 |
46 | MP0002733_abnormal_thermal_nociception | 1.36605414 |
47 | MP0002751_abnormal_autonomic_nervous | 1.35859908 |
48 | MP0005332_abnormal_amino_acid | 1.35581038 |
49 | MP0003137_abnormal_impulse_conducting | 1.34477442 |
50 | MP0004085_abnormal_heartbeat | 1.34228092 |
51 | MP0002572_abnormal_emotion/affect_behav | 1.33526607 |
52 | MP0002249_abnormal_larynx_morphology | 1.31642184 |
53 | MP0010386_abnormal_urinary_bladder | 1.30670706 |
54 | MP0000462_abnormal_digestive_system | 1.29883491 |
55 | MP0001765_abnormal_ion_homeostasis | 1.28187347 |
56 | MP0001664_abnormal_digestion | 1.27105689 |
57 | MP0004130_abnormal_muscle_cell | 1.25790722 |
58 | MP0002882_abnormal_neuron_morphology | 1.25250021 |
59 | MP0010234_abnormal_vibrissa_follicle | 1.25077527 |
60 | MP0001970_abnormal_pain_threshold | 1.19342890 |
61 | MP0002736_abnormal_nociception_after | 1.16793854 |
62 | MP0001501_abnormal_sleep_pattern | 1.16270692 |
63 | MP0005646_abnormal_pituitary_gland | 1.15656659 |
64 | MP0000013_abnormal_adipose_tissue | 1.15421992 |
65 | MP0005330_cardiomyopathy | 1.14600869 |
66 | MP0002118_abnormal_lipid_homeostasis | 1.13219816 |
67 | MP0001486_abnormal_startle_reflex | 1.13094605 |
68 | MP0004264_abnormal_extraembryonic_tissu | 1.12950383 |
69 | MP0004145_abnormal_muscle_electrophysio | 1.12350197 |
70 | MP0002078_abnormal_glucose_homeostasis | 1.11903969 |
71 | MP0005535_abnormal_body_temperature | 1.10482166 |
72 | MP0005187_abnormal_penis_morphology | 1.08972493 |
73 | MP0002972_abnormal_cardiac_muscle | 1.07308472 |
74 | MP0001440_abnormal_grooming_behavior | 1.06888242 |
75 | MP0002876_abnormal_thyroid_physiology | 1.06100985 |
76 | MP0005620_abnormal_muscle_contractility | 1.03879579 |
77 | MP0002067_abnormal_sensory_capabilities | 1.03500920 |
78 | MP0003011_delayed_dark_adaptation | 1.01830502 |
79 | MP0002269_muscular_atrophy | 1.00810126 |
80 | MP0004019_abnormal_vitamin_homeostasis | 1.00424208 |
81 | MP0004924_abnormal_behavior | 1.00388570 |
82 | MP0005386_behavior/neurological_phenoty | 1.00388570 |
83 | MP0005670_abnormal_white_adipose | 1.00035383 |
84 | MP0008775_abnormal_heart_ventricle | 0.99372995 |
85 | MP0008569_lethality_at_weaning | 0.99158156 |
86 | MP0000579_abnormal_nail_morphology | 0.98824451 |
87 | MP0003868_abnormal_feces_composition | 0.97767974 |
88 | MP0001502_abnormal_circadian_rhythm | 0.96723496 |
89 | MP0000749_muscle_degeneration | 0.96508308 |
90 | MP0001984_abnormal_olfaction | 0.95755636 |
91 | MP0001756_abnormal_urination | 0.94820730 |
92 | MP0003879_abnormal_hair_cell | 0.94670107 |
93 | MP0003942_abnormal_urinary_system | 0.94057398 |
94 | MP0003633_abnormal_nervous_system | 0.93751364 |
95 | MP0000230_abnormal_systemic_arterial | 0.92344277 |
96 | MP0000537_abnormal_urethra_morphology | 0.92300618 |
97 | MP0004087_abnormal_muscle_fiber | 0.91926125 |
98 | MP0002557_abnormal_social/conspecific_i | 0.91445281 |
99 | MP0002152_abnormal_brain_morphology | 0.91026625 |
100 | MP0004233_abnormal_muscle_weight | 0.90959026 |
101 | MP0002184_abnormal_innervation | 0.90554032 |
102 | MP0004811_abnormal_neuron_physiology | 0.89743915 |
103 | MP0001944_abnormal_pancreas_morphology | 0.89458557 |
104 | MP0001485_abnormal_pinna_reflex | 0.87523526 |
105 | MP0000955_abnormal_spinal_cord | 0.87441683 |
106 | MP0002234_abnormal_pharynx_morphology | 0.86591905 |
107 | MP0003183_abnormal_peptide_metabolism | 0.85963823 |
108 | MP0004484_altered_response_of | 0.85760162 |
109 | MP0000747_muscle_weakness | 0.84841369 |
110 | MP0003705_abnormal_hypodermis_morpholog | 0.84409404 |
111 | MP0005551_abnormal_eye_electrophysiolog | 0.83965262 |
112 | MP0000538_abnormal_urinary_bladder | 0.83886066 |
113 | MP0001188_hyperpigmentation | 0.83101609 |
114 | MP0009643_abnormal_urine_homeostasis | 0.82943348 |
115 | MP0003953_abnormal_hormone_level | 0.82614217 |
116 | MP0003634_abnormal_glial_cell | 0.80432356 |
117 | MP0003861_abnormal_nervous_system | 0.79887036 |
118 | MP0003122_maternal_imprinting | 0.79310859 |
119 | MP0002069_abnormal_eating/drinking_beha | 0.78847164 |
120 | MP0002752_abnormal_somatic_nervous | 0.78380790 |
121 | MP0002229_neurodegeneration | 0.77875788 |
122 | MP0004885_abnormal_endolymph | 0.77762944 |
123 | MP0008872_abnormal_physiological_respon | 0.76668688 |
124 | MP0002693_abnormal_pancreas_physiology | 0.76504428 |
125 | MP0005448_abnormal_energy_balance | 0.76264239 |
126 | MP0005636_abnormal_mineral_homeostasis | 0.75650061 |
127 | MP0002066_abnormal_motor_capabilities/c | 0.75298449 |
128 | MP0001905_abnormal_dopamine_level | 0.74930780 |
129 | MP0001346_abnormal_lacrimal_gland | 0.74680620 |
130 | MP0005645_abnormal_hypothalamus_physiol | 0.74614147 |
131 | MP0003632_abnormal_nervous_system | 0.74562615 |
132 | MP0002089_abnormal_postnatal_growth/wei | 0.73326907 |
133 | MP0003631_nervous_system_phenotype | 0.73232461 |
134 | MP0005248_abnormal_Harderian_gland | 0.68848530 |
135 | MP0003121_genomic_imprinting | 0.67185148 |
136 | MP0000631_abnormal_neuroendocrine_gland | 0.67112247 |
137 | MP0001348_abnormal_lacrimal_gland | 0.64887811 |
138 | MP0000026_abnormal_inner_ear | 0.62756024 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Sudden death (HP:0001699) | 3.77082034 |
2 | Ketoacidosis (HP:0001993) | 3.76195054 |
3 | Ventricular fibrillation (HP:0001663) | 3.68235565 |
4 | Syncope (HP:0001279) | 3.50006339 |
5 | Bundle branch block (HP:0011710) | 3.36719230 |
6 | Myokymia (HP:0002411) | 3.34172970 |
7 | Right ventricular cardiomyopathy (HP:0011663) | 3.31666092 |
8 | Ketosis (HP:0001946) | 3.31519093 |
9 | Hypoglycemic coma (HP:0001325) | 3.23932970 |
10 | Hyperinsulinemic hypoglycemia (HP:0000825) | 3.20849848 |
11 | Prolonged QT interval (HP:0001657) | 3.20647094 |
12 | Akinesia (HP:0002304) | 3.19472593 |
13 | Obstructive sleep apnea (HP:0002870) | 3.04954595 |
14 | Gout (HP:0001997) | 2.97660305 |
15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.97637857 |
16 | Focal motor seizures (HP:0011153) | 2.91016813 |
17 | Intrahepatic cholestasis (HP:0001406) | 2.86207877 |
18 | Febrile seizures (HP:0002373) | 2.84366937 |
19 | Pheochromocytoma (HP:0002666) | 2.80810624 |
20 | Hypoglycemic seizures (HP:0002173) | 2.74808949 |
21 | Visual hallucinations (HP:0002367) | 2.71790303 |
22 | Focal seizures (HP:0007359) | 2.70367530 |
23 | Deep venous thrombosis (HP:0002625) | 2.66963573 |
24 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.66130901 |
25 | Hyperparathyroidism (HP:0000843) | 2.62307333 |
26 | Ventricular arrhythmia (HP:0004308) | 2.60993293 |
27 | Palpitations (HP:0001962) | 2.59954324 |
28 | Atrial fibrillation (HP:0005110) | 2.54865542 |
29 | Action tremor (HP:0002345) | 2.54245630 |
30 | Late onset (HP:0003584) | 2.50100357 |
31 | Heart block (HP:0012722) | 2.48144357 |
32 | Abnormal EKG (HP:0003115) | 2.45933441 |
33 | Hypercortisolism (HP:0001578) | 2.45820805 |
34 | Central scotoma (HP:0000603) | 2.45294500 |
35 | Xanthomatosis (HP:0000991) | 2.43937280 |
36 | Ventricular tachycardia (HP:0004756) | 2.42360871 |
37 | Primary atrial arrhythmia (HP:0001692) | 2.41616787 |
38 | Exercise-induced myalgia (HP:0003738) | 2.39663758 |
39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.39026892 |
40 | Hyporeflexia of lower limbs (HP:0002600) | 2.37786518 |
41 | Hypoventilation (HP:0002791) | 2.36356678 |
42 | Myoglobinuria (HP:0002913) | 2.34425299 |
43 | Bronchomalacia (HP:0002780) | 2.33124886 |
44 | Atrioventricular block (HP:0001678) | 2.32490663 |
45 | Dysmetric saccades (HP:0000641) | 2.31565516 |
46 | Hyperglycemia (HP:0003074) | 2.30258769 |
47 | Abnormal atrioventricular conduction (HP:0005150) | 2.26235535 |
48 | Conjugated hyperbilirubinemia (HP:0002908) | 2.25673185 |
49 | Amblyopia (HP:0000646) | 2.24948936 |
50 | Supraventricular tachycardia (HP:0004755) | 2.24503891 |
51 | Neuroendocrine neoplasm (HP:0100634) | 2.24471716 |
52 | Hyperammonemia (HP:0001987) | 2.21310806 |
53 | Supraventricular arrhythmia (HP:0005115) | 2.18403386 |
54 | Symptomatic seizures (HP:0011145) | 2.18087758 |
55 | Sleep apnea (HP:0010535) | 2.17282207 |
56 | Hyperglycinuria (HP:0003108) | 2.16744746 |
57 | Shawl scrotum (HP:0000049) | 2.16203589 |
58 | Hyperactive renin-angiotensin system (HP:0000841) | 2.13992996 |
59 | Fetal akinesia sequence (HP:0001989) | 2.13579056 |
60 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.13422405 |
61 | Skin nodule (HP:0200036) | 2.12866738 |
62 | Increased circulating renin level (HP:0000848) | 2.11302048 |
63 | Agitation (HP:0000713) | 2.10683844 |
64 | Supranuclear gaze palsy (HP:0000605) | 2.09937181 |
65 | Abnormal social behavior (HP:0012433) | 2.09095695 |
66 | Impaired social interactions (HP:0000735) | 2.09095695 |
67 | Bicornuate uterus (HP:0000813) | 2.07639568 |
68 | Adrenal overactivity (HP:0002717) | 2.04659087 |
69 | Neurofibrillary tangles (HP:0002185) | 2.02452084 |
70 | Calf muscle hypertrophy (HP:0008981) | 2.02435114 |
71 | Abnormal pancreas size (HP:0012094) | 2.01339353 |
72 | Abnormality of the lower motor neuron (HP:0002366) | 2.01276257 |
73 | Limb dystonia (HP:0002451) | 2.00159735 |
74 | Decreased circulating renin level (HP:0003351) | 1.99366803 |
75 | Abnormality of the aortic arch (HP:0012303) | 1.98382072 |
76 | Generalized tonic-clonic seizures (HP:0002069) | 1.97931880 |
77 | Depression (HP:0000716) | 1.97458800 |
78 | Abnormality of renin-angiotensin system (HP:0000847) | 1.96989448 |
79 | Turricephaly (HP:0000262) | 1.96740390 |
80 | Progressive cerebellar ataxia (HP:0002073) | 1.95934359 |
81 | Hyperventilation (HP:0002883) | 1.94029823 |
82 | Hyperglycinemia (HP:0002154) | 1.93986768 |
83 | Hyperacusis (HP:0010780) | 1.93367228 |
84 | Metabolic alkalosis (HP:0200114) | 1.93270042 |
85 | Genetic anticipation (HP:0003743) | 1.92768192 |
86 | Abnormality of glycine metabolism (HP:0010895) | 1.92656366 |
87 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.92656366 |
88 | Abnormality of the parathyroid morphology (HP:0011766) | 1.92333633 |
89 | Anxiety (HP:0000739) | 1.91858473 |
90 | Status epilepticus (HP:0002133) | 1.91567966 |
91 | Postural instability (HP:0002172) | 1.90801705 |
92 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.90576876 |
93 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.90299641 |
94 | Abnormality of purine metabolism (HP:0004352) | 1.90113687 |
95 | Hyperphosphatemia (HP:0002905) | 1.88252427 |
96 | Neoplasm of the heart (HP:0100544) | 1.87892419 |
97 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.87423560 |
98 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.87423560 |
99 | Absence seizures (HP:0002121) | 1.87242489 |
100 | Torticollis (HP:0000473) | 1.86238711 |
101 | Neonatal onset (HP:0003623) | 1.83943299 |
102 | Epidermoid cyst (HP:0200040) | 1.83894775 |
103 | Visceral angiomatosis (HP:0100761) | 1.83891057 |
104 | Abnormal eating behavior (HP:0100738) | 1.83855782 |
105 | Asymmetric septal hypertrophy (HP:0001670) | 1.83458173 |
106 | Ankle clonus (HP:0011448) | 1.81518112 |
107 | EEG with generalized epileptiform discharges (HP:0011198) | 1.81459237 |
108 | Spastic gait (HP:0002064) | 1.80369210 |
109 | Hypsarrhythmia (HP:0002521) | 1.78925802 |
110 | Macroorchidism (HP:0000053) | 1.78850747 |
111 | Annular pancreas (HP:0001734) | 1.78807765 |
112 | Complement deficiency (HP:0004431) | 1.78207603 |
113 | Lymphangioma (HP:0100764) | 1.77953786 |
114 | Dysdiadochokinesis (HP:0002075) | 1.77862929 |
115 | Abnormality of the calf musculature (HP:0001430) | 1.76360159 |
116 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.76283969 |
117 | Aplasia of the phalanges of the hand (HP:0009802) | 1.76283969 |
118 | Aplasia involving bones of the extremities (HP:0009825) | 1.76283969 |
119 | Epileptiform EEG discharges (HP:0011182) | 1.76250731 |
120 | Atonic seizures (HP:0010819) | 1.75436579 |
121 | Myotonia (HP:0002486) | 1.75349044 |
122 | Poor eye contact (HP:0000817) | 1.74905356 |
123 | Prolonged partial thromboplastin time (HP:0003645) | 1.74529788 |
124 | Alkalosis (HP:0001948) | 1.74526449 |
125 | Epileptic encephalopathy (HP:0200134) | 1.74198126 |
126 | Hyperlipoproteinemia (HP:0010980) | 1.73703537 |
127 | Failure to thrive in infancy (HP:0001531) | 1.73435947 |
128 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.72683987 |
129 | Shallow orbits (HP:0000586) | 1.72279853 |
130 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.72067240 |
131 | Exotropia (HP:0000577) | 1.71489801 |
132 | Diminished movement (HP:0002374) | 1.70942339 |
133 | Bowel diverticulosis (HP:0005222) | 1.70188368 |
134 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.70158522 |
135 | Abnormality of pain sensation (HP:0010832) | 1.69835219 |
136 | Impaired pain sensation (HP:0007328) | 1.69835219 |
137 | Distal upper limb amyotrophy (HP:0007149) | 1.69727443 |
138 | Upper limb amyotrophy (HP:0009129) | 1.69727443 |
139 | Hypercalciuria (HP:0002150) | 1.69458882 |
140 | Potter facies (HP:0002009) | 1.69189755 |
141 | Facial shape deformation (HP:0011334) | 1.69189755 |
142 | Dysmetria (HP:0001310) | 1.68441908 |
143 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.68179539 |
144 | Lower limb amyotrophy (HP:0007210) | 1.66675325 |
145 | Intention tremor (HP:0002080) | 1.66029380 |
146 | Cerebral inclusion bodies (HP:0100314) | 1.64538962 |
147 | Germ cell neoplasia (HP:0100728) | 1.63530677 |
148 | Hyperaldosteronism (HP:0000859) | 1.63497368 |
149 | Buphthalmos (HP:0000557) | 1.63279457 |
150 | Papilledema (HP:0001085) | 1.61993233 |
151 | Hemangiomatosis (HP:0007461) | 1.60039165 |
152 | Enlarged penis (HP:0000040) | 1.56540977 |
153 | Hypercalcemia (HP:0003072) | 1.56459585 |
154 | Growth hormone excess (HP:0000845) | 1.56224610 |
155 | Dialeptic seizures (HP:0011146) | 1.53876125 |
156 | Polyphagia (HP:0002591) | 1.53790448 |
157 | Renovascular hypertension (HP:0100817) | 1.52070225 |
158 | Cerebral aneurysm (HP:0004944) | 1.51598957 |
159 | Focal dystonia (HP:0004373) | 1.51530861 |
160 | Popliteal pterygium (HP:0009756) | 1.50870969 |
161 | Hypothermia (HP:0002045) | 1.50234959 |
162 | Clonus (HP:0002169) | 1.50084976 |
163 | Truncal ataxia (HP:0002078) | 1.49444197 |
164 | Insomnia (HP:0100785) | 1.49180896 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 3.28600565 |
2 | LMTK2 | 2.92660543 |
3 | CASK | 2.91814664 |
4 | NTRK3 | 2.89068348 |
5 | MAP3K9 | 2.57761079 |
6 | INSRR | 2.56965694 |
7 | PRKD3 | 2.28952021 |
8 | MAP3K4 | 2.07985032 |
9 | WNK4 | 2.05450484 |
10 | DAPK2 | 2.00687614 |
11 | NTRK1 | 1.99618521 |
12 | MUSK | 1.98960999 |
13 | PHKG2 | 1.84159526 |
14 | PHKG1 | 1.84159526 |
15 | EPHA4 | 1.83974878 |
16 | KSR2 | 1.82092068 |
17 | MAP3K2 | 1.80788948 |
18 | STK38 | 1.79665668 |
19 | MAP2K4 | 1.78988651 |
20 | CAMKK1 | 1.75308137 |
21 | RIPK1 | 1.68686862 |
22 | MINK1 | 1.65076183 |
23 | FGFR2 | 1.62753698 |
24 | PAK6 | 1.62284450 |
25 | TRIB3 | 1.56210844 |
26 | MARK1 | 1.54968929 |
27 | BCKDK | 1.51129379 |
28 | MET | 1.45501947 |
29 | SIK1 | 1.44535488 |
30 | PAK3 | 1.42540162 |
31 | CDC42BPA | 1.31562143 |
32 | FRK | 1.27844280 |
33 | WNK3 | 1.24275591 |
34 | PINK1 | 1.22841346 |
35 | PDK4 | 1.21541583 |
36 | PDK3 | 1.21541583 |
37 | MYLK | 1.19419237 |
38 | RET | 1.18671840 |
39 | PKN2 | 1.16873807 |
40 | MAP2K7 | 1.14225718 |
41 | WNK1 | 1.13521754 |
42 | PDGFRA | 1.10601116 |
43 | SGK223 | 1.07909918 |
44 | SGK494 | 1.07909918 |
45 | MAP3K1 | 1.04203863 |
46 | FER | 1.04037403 |
47 | DMPK | 1.02170034 |
48 | TAOK3 | 1.01367748 |
49 | CAMK2B | 0.99617713 |
50 | MAP3K7 | 0.99531466 |
51 | SGK3 | 0.99211400 |
52 | NTRK2 | 0.97396963 |
53 | UHMK1 | 0.96432054 |
54 | CDK5 | 0.96095498 |
55 | CAMK1G | 0.94027118 |
56 | PRKAA1 | 0.92761589 |
57 | ERN1 | 0.92732264 |
58 | PRKCH | 0.92426098 |
59 | KSR1 | 0.91807806 |
60 | NEK1 | 0.90739011 |
61 | SGK2 | 0.90212158 |
62 | AKT3 | 0.88202077 |
63 | CAMK2D | 0.86451327 |
64 | TESK1 | 0.85835643 |
65 | GRK5 | 0.85140921 |
66 | PTK2 | 0.83526104 |
67 | TTN | 0.82035115 |
68 | TAOK1 | 0.78908982 |
69 | DDR2 | 0.78802018 |
70 | OXSR1 | 0.78483117 |
71 | CAMKK2 | 0.77554269 |
72 | ICK | 0.76607900 |
73 | LATS2 | 0.75615616 |
74 | ERBB2 | 0.75184179 |
75 | OBSCN | 0.75127788 |
76 | PTK6 | 0.74691498 |
77 | FGFR4 | 0.74197693 |
78 | MST1R | 0.73317827 |
79 | CAMK2A | 0.71425978 |
80 | RPS6KA2 | 0.71268486 |
81 | PDPK1 | 0.69195128 |
82 | ROCK1 | 0.68062635 |
83 | NEK6 | 0.66940989 |
84 | STK11 | 0.66386276 |
85 | DYRK1B | 0.66033661 |
86 | CAMK1 | 0.65915371 |
87 | PRKCG | 0.65687760 |
88 | MTOR | 0.65641922 |
89 | MAP2K1 | 0.65613268 |
90 | STK39 | 0.65222396 |
91 | DYRK1A | 0.64268440 |
92 | PNCK | 0.63608517 |
93 | PRKCZ | 0.63156353 |
94 | SIK2 | 0.62844348 |
95 | PRKD1 | 0.62075296 |
96 | MARK2 | 0.61578422 |
97 | PIK3CA | 0.60467970 |
98 | PRKG2 | 0.59870420 |
99 | CAMK2G | 0.59841553 |
100 | EPHB2 | 0.58417261 |
101 | CAMK4 | 0.57663762 |
102 | CDK15 | 0.55966827 |
103 | PRKACG | 0.55289290 |
104 | TYRO3 | 0.55183232 |
105 | PRKAA2 | 0.53949398 |
106 | PDK1 | 0.53925113 |
107 | CDK18 | 0.53450734 |
108 | MAPK13 | 0.52994018 |
109 | CAMK1D | 0.52500287 |
110 | SGK1 | 0.52305232 |
111 | HIPK2 | 0.50463309 |
112 | CDK11A | 0.48570553 |
113 | RPS6KA3 | 0.48117957 |
114 | PDGFRB | 0.47916838 |
115 | DYRK2 | 0.47910801 |
116 | PDK2 | 0.47489816 |
117 | EEF2K | 0.47451597 |
118 | PRKCE | 0.46164739 |
119 | DAPK1 | 0.45606395 |
120 | ALK | 0.45145257 |
121 | ROCK2 | 0.44611309 |
122 | PRKCI | 0.44310103 |
123 | MAPK15 | 0.44116676 |
124 | MAPK8 | 0.44099832 |
125 | CDK14 | 0.43681075 |
126 | EPHA3 | 0.43265178 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.69713494 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.64673415 |
3 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.01510813 |
4 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.98952782 |
5 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.95540604 |
6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.86955991 |
7 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.84602447 |
8 | Insulin secretion_Homo sapiens_hsa04911 | 1.82715912 |
9 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.80881330 |
10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.72601904 |
11 | Bile secretion_Homo sapiens_hsa04976 | 1.71492070 |
12 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69707570 |
13 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.68338436 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64029804 |
15 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.61602453 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52764809 |
17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.45984280 |
18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.45471761 |
19 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.40069573 |
20 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37343412 |
21 | Axon guidance_Homo sapiens_hsa04360 | 1.36525630 |
22 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.36505990 |
23 | Circadian entrainment_Homo sapiens_hsa04713 | 1.35385286 |
24 | GABAergic synapse_Homo sapiens_hsa04727 | 1.33810646 |
25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.30481833 |
26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.26185047 |
27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.26055351 |
28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.24211178 |
29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.21298254 |
30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.21271270 |
31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.18310794 |
32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.17157341 |
33 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.16586063 |
34 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.16046034 |
35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.13621940 |
36 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13126508 |
37 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.12311709 |
38 | Olfactory transduction_Homo sapiens_hsa04740 | 1.10838720 |
39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10814312 |
40 | Salivary secretion_Homo sapiens_hsa04970 | 1.10512889 |
41 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.08512723 |
42 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.07883113 |
43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.05298484 |
44 | Taste transduction_Homo sapiens_hsa04742 | 1.00370483 |
45 | Tight junction_Homo sapiens_hsa04530 | 0.99920946 |
46 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.99895586 |
47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.99764112 |
48 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.99073750 |
49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.98055766 |
50 | Morphine addiction_Homo sapiens_hsa05032 | 0.97365823 |
51 | Cocaine addiction_Homo sapiens_hsa05030 | 0.97125097 |
52 | Retinol metabolism_Homo sapiens_hsa00830 | 0.96930979 |
53 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.95984166 |
54 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94111761 |
55 | Renin secretion_Homo sapiens_hsa04924 | 0.93649161 |
56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.93509954 |
57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92712177 |
58 | Melanogenesis_Homo sapiens_hsa04916 | 0.91359885 |
59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.90390275 |
60 | ABC transporters_Homo sapiens_hsa02010 | 0.89663863 |
61 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.89628959 |
62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.89459513 |
63 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.86668209 |
64 | Carbon metabolism_Homo sapiens_hsa01200 | 0.84332951 |
65 | Peroxisome_Homo sapiens_hsa04146 | 0.83076294 |
66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.82825885 |
67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.82747365 |
68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.81816888 |
69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78026263 |
70 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77511983 |
71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76197955 |
72 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.76188781 |
73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.74857720 |
74 | Insulin resistance_Homo sapiens_hsa04931 | 0.74213079 |
75 | Lysine degradation_Homo sapiens_hsa00310 | 0.73738922 |
76 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.73486421 |
77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71897977 |
78 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71813936 |
79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71480964 |
80 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69686313 |
81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.68971187 |
82 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.68945190 |
83 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67727558 |
84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66978731 |
85 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66701769 |
86 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.66257654 |
87 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.65823416 |
88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.65134865 |
89 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.64169749 |
90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.63998344 |
91 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63268343 |
92 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.62949340 |
93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61857385 |
94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.61690104 |
95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.61476863 |
96 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.60606650 |
97 | Glioma_Homo sapiens_hsa05214 | 0.59743169 |
98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.59357580 |
99 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59322788 |
100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.59211161 |
101 | Gap junction_Homo sapiens_hsa04540 | 0.58568157 |
102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58413319 |
103 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.57896084 |
104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.56873966 |
105 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.55765063 |
106 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.53159491 |
107 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.52704654 |
108 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52655961 |
109 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.51244547 |
110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.49821717 |
111 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.49598900 |
112 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.49477684 |
113 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49395076 |
114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.48543893 |
115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.47205575 |
116 | Long-term depression_Homo sapiens_hsa04730 | 0.47079674 |
117 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46959599 |
118 | Mineral absorption_Homo sapiens_hsa04978 | 0.46842210 |
119 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46265597 |
120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46152608 |
121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.45893844 |
122 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.44811598 |
123 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.43860575 |
124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43200003 |
125 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42220317 |